Medical Procedure News

RSS

Health Canada approves NDSsi's ZeroWire wireless surgical video technology

NDS Surgical Imaging (NDSsi) today announced it received Health Canada approval for its ZeroWire wireless surgical video technology.

16 Nov 2011

EMA grants orphan designation to AMT for hemophilia B gene therapy

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency (EMA) has granted orphan designation for its gene therapy program for the treatment of hemophilia B. Orphan designation in the European Union provides several benefits including 10 years of market exclusivity from product launch and access to the central authorization procedure.

16 Nov 2011

ProFibrix Fibrocaps effectively reduces bleeding in liver resection surgery

ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that its multicenter Phase II clinical trial with Fibrocaps in liver resection surgery resulted in a highly statistically significant 50% reduction in mean time to hemostasis (TTH) compared to active control.

15 Nov 2011

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.

15 Nov 2011

Stem cell therapy within 2 or 3 weeks does not improve heart function after attack

A research network led by a Mayo Clinic physician found that stem cells obtained from bone marrow delivered two to three weeks after a person has a heart attack did not improve heart function.

15 Nov 2011

Stem cell injections within two weeks may not help in post heart attack recovery

University Hospitals Case Medical Center researchers could still be close to giving heart attack patients a second chance-just not as they originally thought.

15 Nov 2011

Delay in hypothermia, ROSC linked with poor post cardiac arrest neurologic outcomes

Delay in initiation of therapeutic hypothermia and delay in return of spontaneous circulation (ROSC), evidenced by a palpable pulse or a measurable blood pressure, were both associated with poor neurologic outcomes in post cardiac arrest patients, according to a study being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla.

15 Nov 2011

CAS after prior revascularization safe, effective for carotid artery stenosis patients

A new study shows that carotid artery stenting (CAS) following prior same-side carotid artery revascularization is safe, effective and results in lower incidences of in-hospital death, stroke and heart attack compared to first-time CAS for carotid artery stenosis.

15 Nov 2011

Study compares safety of procedures at hospitals with and without cardiac surgery backup

Hospitals that do not have cardiac surgery capability can perform nonemergency angioplasty and stent implantation as safely as hospitals that do offer cardiac surgery. That is the finding of the nation's first large, randomized study to assess whether patients do just as well having nonemergency angioplasty performed at smaller, community hospitals that do not offer cardiac surgery.

15 Nov 2011

Researchers examine optimal timing for carotid artery stenting after TIA or stroke

A recent study found no significant difference in the outcome for patients who received carotid artery stenting (CAS) at more than 30 days post-transient ischemic attack (TIA) or stroke versus those who received CAS at 30 days or less post-event.

15 Nov 2011

Lentigen, UH Case Medical Center initiate LG631 Phase I trial in glioblastoma

University Hospitals (UH) Case Medical Center, Case Western Reserve University School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting toxicity of chemotherapy with Temodar.

15 Nov 2011

Mesoblast reports positive Revascor Phase 2 heart failure trial results

Regenerative medicine company Mesoblast Limited today announced positive Phase 2 heart failure trial results of its allogeneic, or off-the-shelf, adult stem cell product Revascor after all patients had completed a minimum follow-up of 12 months, and a mean follow-up of 22 months.

15 Nov 2011

Link between hysterectomy and early menopause among younger women

In a finding that confirms what many obstetricians and gynecologists suspected, Duke University researchers report that younger women who undergo hysterectomies face a nearly two-fold increased risk for developing menopause early.

14 Nov 2011

Cultured ES cells can self-organize into three-dimensional tissue-like structures

The possibility that functional, three-dimensional tissues and organs may be derived from pluripotent cells, such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), represents one of the grand challenges of stem cell research, but is also one of the fundamental goals of the emerging field of regenerative medicine.

14 Nov 2011

Surgery to treat lung cancer would increase survival rates

Many more lung cancer patients would survive for longer if they had surgery to remove the disease, according to research published in the European Journal of Cancer.

14 Nov 2011

Functional MRI illuminates brain networks activated by motion

An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control. Patients with generalized dystonia grapple with involuntary muscle spasms that lead to uncontrolled twisting and turning in awkward, sometimes painful postures.

14 Nov 2011

Therapeutic hypothermia recommended for patients with preexisting cardiomyopathy

Cardiomyopathy is common among cardiac arrest survivors. The survival and neuroprotective benefits of therapeutic hypothermia is similar in patients with preexisting cardiomyopathy, compared with those patients without cardiomyopathy, according to a scientific poster being presented Nov. 14 at the American Heart Association (AHA) scientific sessions.

14 Nov 2011

Demand for non-drug intervention for atrial fibrillation will remain, despite FDA PVAC decision

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).

From Medtronic 14 Nov 2011

Data shows cost-effectiveness of ZOLL LifeVest Wearable Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that data showing the cost-effectiveness of the LifeVest Wearable Defibrillator was presented in two scientific presentations and posters at the American Heart Association's Scientific Sessions 2011 in Orlando over the weekend.

14 Nov 2011

Harrison Medical Center installs three Toshiba Infinix-i vascular X-ray systems

Performing cardiac catheterizations through the radial artery is proven to make exams safer for patients while frequently reducing post-procedure hospital stay times. To conduct radial interventions from both the right and left side, Harrison Medical Center in Bremerton, Wash., installed three Infinix™-i vascular X-ray systems from Toshiba America Medical Systems, Inc.

14 Nov 2011

Medical Procedure News

Health Canada approves NDSsi's ZeroWire wireless surgical video technology

EMA grants orphan designation to AMT for hemophilia B gene therapy

ProFibrix Fibrocaps effectively reduces bleeding in liver resection surgery

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Stem cell therapy within 2 or 3 weeks does not improve heart function after attack

Stem cell injections within two weeks may not help in post heart attack recovery

Delay in hypothermia, ROSC linked with poor post cardiac arrest neurologic outcomes

CAS after prior revascularization safe, effective for carotid artery stenosis patients

Study compares safety of procedures at hospitals with and without cardiac surgery backup

Researchers examine optimal timing for carotid artery stenting after TIA or stroke

Lentigen, UH Case Medical Center initiate LG631 Phase I trial in glioblastoma

Mesoblast reports positive Revascor Phase 2 heart failure trial results

Link between hysterectomy and early menopause among younger women

Cultured ES cells can self-organize into three-dimensional tissue-like structures

Surgery to treat lung cancer would increase survival rates

Functional MRI illuminates brain networks activated by motion

Therapeutic hypothermia recommended for patients with preexisting cardiomyopathy

Demand for non-drug intervention for atrial fibrillation will remain, despite FDA PVAC decision

Data shows cost-effectiveness of ZOLL LifeVest Wearable Defibrillator

Harrison Medical Center installs three Toshiba Infinix-i vascular X-ray systems

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News